3P Biotechnologies, Inc.
Prospect, KY Doing business as 3P Biotechnologies
- UEI
- HSCNW2K7VN97
- CAGE
- 5KJ71
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3205 Hidden Springs Ln, Prospect, KY 40059, USA
- Website
- 3pbiotechnologies.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Trans spinal delivery of targeted exosomal formulation of curcuminoids to treat ad - technical abstract… | National Institute on Aging | $506,434 | |
| Trans spinal delivery of a targeted nanoformulation of curcuminoids to treat ad - technical abstract neurodegenerative… | National Institute on Aging | $1,519,392 | |
| Targeted exosomal delivery of sirna therapeutics for neuroinflammatory diseases - technical abstract neurodegenerative… | National Institute on Aging | $506,451 | |
| Engineered exosomes for targeted delivery of the crispr/CAS9 genome-editor - technical abstract genetic mutations have… | Aggregate Financial Assistance Data | $264,507 | |
| Exosomal drug delivery | National Cancer Institute | $1,719,680 |
About 3P Biotechnologies, Inc.
3P Biotechnologies, Inc. is a for-profit, Subchapter S Corporation registered in the System for Award Management (SAM) since July 2009, with its registration set to expire on January 30, 2026. Located in Prospect, Kentucky, the company specializes in advanced biotechnology research focused on innovative drug delivery systems and therapeutic interventions, particularly in the neurological disease domain. The organization demonstrates expertise in exosome technologies, drug delivery mechanisms, plant-derived therapeutics, and advanced genomic editing approaches.
The company has secured multiple federal grants from the National Institute on Aging and the Office of the Director, primarily targeting neuroinflammatory disease research and treatment, with a specific focus on Alzheimer's disease. Their recent federal grant awards, totaling approximately $506,434, have centered on developing targeted delivery systems for bioactive compounds like curcuminoids and siRNA therapeutics. These projects involve sophisticated research methodologies, including trans-spinal delivery of exosomal formulations, development of targeted nanoformulations, and innovative genome editing techniques using CRISPR/Cas9 technology. The grants demonstrate 3P Biotechnologies' commitment to creating advanced therapeutic approaches that can more effectively cross the blood-brain barrier and mitigate neuroinflammatory conditions through precise, targeted molecular interventions.
Quick answers
What is 3P Biotechnologies, Inc.'s UEI?
3P Biotechnologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is HSCNW2K7VN97.
What is 3P Biotechnologies, Inc.'s CAGE code?
3P Biotechnologies, Inc.'s CAGE code is 5KJ71.
What is 3P Biotechnologies, Inc.'s primary NAICS code?
3P Biotechnologies, Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is 3P Biotechnologies, Inc. located?
3P Biotechnologies, Inc.'s physical address in SAM.gov is 3205 Hidden Springs Ln, Prospect, KY 40059, USA.
Is 3P Biotechnologies, Inc. registered in SAM.gov?
Yes. 3P Biotechnologies, Inc.'s SAM.gov registration is active through January 5, 2027.
What is 3P Biotechnologies, Inc.'s most recent federal award?
3P Biotechnologies, Inc.'s most recent federal grant award is Trans spinal delivery of targeted exosomal formulation of curcuminoids to treat ad - technical abstract… (R41AG090217), from National Institute on Aging, on September 15, 2025.
On GovTribe
See 3P Biotechnologies, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors